ZYLOXTB(02190),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02190 ZYLOXTB

Not Yet Opened 03-04 16:08:16

20.460

-0.040

-0.20%

High22.180	Low19.950	Vol1.02M
Open20.000	D1 Closing20.500	Amplitude10.88%
Mkt Cap6.90B	Tradable Cap6.75B	Total Shares337.00M
T/O20.70M	T/O Rate0.31%	Tradable Shares330.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02190","market":"HK","secType":"STK","nameCN":"ZYLOXTB","latestPrice":20.46,"timestamp":1772611696002,"preClose":20.5,"halted":0,"volume":1023053,"delay":0,"changeRate":-0.0019512195121950803,"floatShares":330000000,"shares":337000000,"eps":0.3466464242992847,"marketStatus":"Not Yet Opened","change":-0.04,"latestTime":"03-04 16:08:16","open":20,"high":22.18,"low":19.95,"amount":20704319,"amplitude":0.10878,"askPrice":20.48,"askSize":1500,"bidPrice":20.24,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.5267823669598531,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772674200000},"marketStatusCode":0,"adr":0,"listingDate":1625414400000,"exchange":"SEHK","adjPreClose":20.5,"dividendRate":0.005589,"openAndCloseTimeList":[[1772587800000,1772596800000],[1772600400000,1772611200000]],"volumeRatio":1.199968,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02190/tweets","defaultTab":"tweets","newsList":[{"id":"1180827270","title":"Zylox-Tonbridge (02190) Announces Monthly Return with Unchanged Share Capital for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1180827270","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180827270?lang=en_us&edition=fundamental","pubTime":"2026-03-03 17:06","pubTimestamp":1772528791,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (stock code: 02190) published its monthly return for the month ended 28 February 2026, confirming that total authorized share capital remains at 344.13...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"gpt_icon":0},{"id":"1160049564","title":"Zylox-Tonbridge Medical Technology Co., Ltd. (Stock Code: 2190) Announces Upcoming Board Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1160049564","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160049564?lang=en_us&edition=fundamental","pubTime":"2026-03-02 17:35","pubTimestamp":1772444159,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (Stock Code: 2190) has announced that its Board of Directors will convene on Tuesday, March 17, 2026. The primary agenda includes reviewing and approving...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"gpt_icon":0},{"id":"1188687090","title":"Zylox-Tonbridge (2190) Announces Further Details on 49% Equity Acquisition and Target’s Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1188687090","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188687090?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:44","pubTimestamp":1770990254,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (2190) has released additional information regarding its acquisition of 49% equity interests in a target company focused on medical technology...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"gpt_icon":0},{"id":"2611157482","title":"Zylox-Tonbridge Medical Acquires 49% Stake in Medical Device Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2611157482","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611157482?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:24","pubTimestamp":1770989076,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge Medical Technology Co., Ltd. announced the acquisition of a 49% equity interest in a target company engaged in the development, manufacturing, and distribution of medical technology products for minimally invasive vascular and endourology procedures. The transaction consideration will be adjusted based on completion accounts, reflecting the target company's actual cash, financial debt, and net working capital at closing. This adjustment mechanism is designed to provide downside protection to Zylox-Tonbridge in light of the target group's historical losses and to better align the interests of both parties. The Board assessed the target's growth potential, comprehensive product offerings, and industry trends as key factors in the investment decision.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL9M7dqD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02190","BK1587","BK1583","BK1100"],"gpt_icon":0},{"id":"1115065970","title":"Zylox-Tonbridge Medical (02190) Announces January 2026 Share Capital and Public Float Status","url":"https://stock-news.laohu8.com/highlight/detail?id=1115065970","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115065970?lang=en_us&edition=fundamental","pubTime":"2026-02-03 17:25","pubTimestamp":1770110739,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (02190) released its monthly return for the period ended 31 January 2026. The total authorised share capital remained at RMB 344,132,001, comprising...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190"],"gpt_icon":0},{"id":"1118873306","title":"Hong Kong Stocks Movement | ZYLOXTB (02190) Surges Nearly 7% Intraday, Strong Core Product Sales Growth; Company Forecasts Full-Year Net Profit to Jump Nearly 140% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1118873306","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118873306?lang=en_us&edition=fundamental","pubTime":"2026-02-03 16:00","pubTimestamp":1770105624,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) rose nearly 7% during the trading session. As of the time of writing, the stock was up 5.65%, trading at HK$25.04, with a turnover of HK$17.88 million. The surge follows the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","BK4585","BK1574","02190","BK1587","VT","BK4588"],"gpt_icon":0},{"id":"2607333810","title":"BRIEF-Zylox-Tonbridge Medical Technology Sees Revenue More Than RMB1.05 Billion For Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2607333810","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607333810?lang=en_us&edition=fundamental","pubTime":"2026-01-29 22:05","pubTimestamp":1769695548,"startTime":"0","endTime":"0","summary":"BRIEF-Zylox-Tonbridge Medical Technology Sees Revenue More Than RMB1.05 Billion For YearJan 29  - Zylox-Tonbridge Medical Technology Co Ltd 2190.HK:SEES REVENUE MORE THAN RMB1.05 BILLION FOR YEARSEES NET PROFIT ATTRIBUTABLE MORE THAN RMB240 MILLION FOR FYFurther company coverage: 2190.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU07T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","02190","BK1100","BK1583"],"gpt_icon":0},{"id":"1115845439","title":"ZYLOXTB (02190) Issues Profit Alert, Anticipates Annual Net Profit Attributable to Shareholders to Exceed RMB 240 Million, Up Approximately 139.4% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1115845439","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115845439?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:02","pubTimestamp":1769691736,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) announced that for the fiscal year ending December 31, 2025 (the reporting period), the net profit attributable to the company's equity holders is expected to exceed RMB 240 million,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","BK1574","02190","BK1587"],"gpt_icon":0},{"id":"2607824280","title":"Zylox-Tonbridge Medical Technology Sees Net Profit Attributable More Than RMB240 Mln for FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2607824280","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607824280?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:49","pubTimestamp":1769690989,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU07T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","02190","BK1587","BK1583","BK1574"],"gpt_icon":0},{"id":"2607082474","title":"Zylox-Tonbridge Expects Significant Profit Growth on Strong Sales and Efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2607082474","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607082474?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:49","pubTimestamp":1769690969,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge Medical Technology Co., Ltd. has announced a significant improvement in its financial performance for the year ended December 31, 2025. The company expects its net profit attributable to equity holders to exceed RMB240 million, reflecting a year-on-year increase of approximately 139.4% compared to RMB100.26 million in 2024. Additionally, revenue for the period is anticipated to surpass RMB1.05 billion, marking a 34.6% rise from RMB0.78 billion in the previous year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zylox-Tonbridge Medical Technology Co .Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 29, 2026,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL5VdyLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","02190","BK1587","BK1583"],"gpt_icon":0},{"id":"2605323553","title":"A Look At Zylox-Tonbridge Medical Technology (SEHK:2190) Valuation After Investor Open Day Showcases Endovascular Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2605323553","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605323553?lang=en_us&edition=fundamental","pubTime":"2026-01-24 15:31","pubTimestamp":1769239919,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge Medical Technology (SEHK:2190) recently hosted an Investor Open Day at its Zhuhai Innovation Center, showcasing its endovascular product portfolio to nearly 150 institutional investors and sell side analysts.\nSee our latest analysis for Zylox-Tonbridge Medical Technology.\nThe Investor Open Day comes after a strong run in the shares, with a 30 day share price return of 16.37% and a 1 year total shareholder return of 135.76%. This suggests momentum has been building rather than...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2190/zylox-tonbridge-medical-technology-shares/news/a-look-at-zylox-tonbridge-medical-technology-sehk2190-valuat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2190/zylox-tonbridge-medical-technology-shares/news/a-look-at-zylox-tonbridge-medical-technology-sehk2190-valuat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","DCF","BK1100","BK1587","BK1583","02190"],"gpt_icon":0},{"id":"2604655181","title":"There's Been No Shortage Of Growth Recently For Zylox-Tonbridge Medical Technology's (HKG:2190) Returns On Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2604655181","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604655181?lang=en_us&edition=fundamental","pubTime":"2026-01-20 08:57","pubTimestamp":1768870645,"startTime":"0","endTime":"0","summary":"To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2190/zylox-tonbridge-medical-technology-shares/news/theres-been-no-shortage-of-growth-recently-for-zylox-tonbrid","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2190/zylox-tonbridge-medical-technology-shares/news/theres-been-no-shortage-of-growth-recently-for-zylox-tonbrid","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1100","BK1574","02190","BK1587","EBIT"],"gpt_icon":0},{"id":"1191415561","title":"Stock Movement | ZYLOXTB (02190) Rises Nearly 5% Intraday; Recent Strategic Acquisition of Germany's Optimed to Further Expand Global Vascular Intervention Market Layout","url":"https://stock-news.laohu8.com/highlight/detail?id=1191415561","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191415561?lang=en_us&edition=fundamental","pubTime":"2026-01-19 10:54","pubTimestamp":1768791258,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) rose nearly 5% during the trading session. As of the time of writing, the stock was up 3.88%, trading at HK$26.26, with a turnover of HK$6.7268 million. On January 16, ZYLOXTB...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","FDXMmain","BK1587","FDAXmain","FDXSmain","02190","BK1100","BK1574"],"gpt_icon":0},{"id":"2603695398","title":"Zylox-Tonbridge to Acquire Equity Interest in a European Medical Device Company to Accelerate Expansion in the Global Medtech Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2603695398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603695398?lang=en_us&edition=fundamental","pubTime":"2026-01-16 10:27","pubTimestamp":1768530467,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nTUA6QWKF5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","BK1587","BK1100","02190"],"gpt_icon":0},{"id":"1150196613","title":"ZYLOXTB (02190) Strategically Acquires Germany's Optimed to Expand Global Vascular Intervention Manufacturing and Commercialization Footprint","url":"https://stock-news.laohu8.com/highlight/detail?id=1150196613","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150196613?lang=en_us&edition=fundamental","pubTime":"2026-01-16 10:20","pubTimestamp":1768530000,"startTime":"0","endTime":"0","summary":"On January 16, ZYLOTB Medical Technology Co., Ltd. (hereinafter referred to as \"ZYLOXTB (02190)\") announced it has signed an agreement with Germany's Optimed Medizinische Instrumente GmbH, a medical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","FDAXmain","FDXMmain","02190","FDXSmain","BK1587","BK1583","BK1100"],"gpt_icon":0},{"id":"1149591971","title":"HK Market Daily: PBOC Cuts Key Rates by 25bps; State Grid Plans 4 Trillion Yuan \"16th Five-Year\" Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1149591971","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149591971?lang=en_us&edition=fundamental","pubTime":"2026-01-16 08:05","pubTimestamp":1768521907,"startTime":"0","endTime":"0","summary":"The People's Bank of China announced that, effective January 19, it will lower the interest rates for relending and rediscount facilities by 0.25 percentage points. This move aims to enhance the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"531ba096f5502f39f4937c4f27f3448f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1594","BK4532","BK1161","ZFmain","BK4574","BK1587","BK1230","BK4505","03993","06936","BK4526","688331","IE0032431581.USD","00001","BK4534","UBmain","LU1048588211.SGD","LU1880383366.USD","BK4509","BK1569","LU0149721374.USD","CKHUY","ZTmain","LU0072462343.USD","LU1969619763.USD","LU2328871848.SGD","LU1571399168.USD","BK1190","LU0708995583.HKD","09866","BK1521","BK1592","LU0052750758.USD","02465","LU2213484517.USD","BK4555","LU0164880469.USD","ZNmain","300919","BK1100","BK4585","BK1151","02190","603906","TNmain","NIO.SI","BK1500","ZBmain","BK4504","LU0320764599.SGD","603993","EVS.SI","BK1574","LU1481107354.HKD","002352","BK1110","BK1601","BK4531","BK1583","BK4588","BK4548","BK4581","02579","LU1880383440.USD","BK4099","NIO","BK1116","09995"],"gpt_icon":1},{"id":"1110351889","title":"ZYLOXTB (02190) to Acquire 49% Stake in Optimed Holding for €18.375 Million, a Key Milestone for Entry into European and Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1110351889","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110351889?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:28","pubTimestamp":1768516112,"startTime":"0","endTime":"0","summary":"On January 16, 2026, ZYLOXTB (02190) announced that the company (as the buyer) entered into a sale and purchase agreement with E-Med Solutions (as the seller). Under the agreement, the buyer agreed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02190","FXE","BK1587","EUO","EURmain","BK1583","MEURmain","BK1574"],"gpt_icon":0},{"id":"2603939848","title":"Zylox-Tonbridge Acquires 49% Stake in Optimed Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2603939848","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603939848?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:12","pubTimestamp":1768515122,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge Medical Technology Co., Ltd. has announced a discloseable transaction involving the acquisition of a 49% equity interest in Optimed Holding GmbH, a company organized under the laws of Germany. The transaction was made pursuant to a Sale and Purchase Agreement entered into on January 16, 2026, between Zylox-Tonbridge as the purchaser and E-Med Solutions as the seller. Completion of the proposed acquisition is subject to the fulfillment or waiver of certain conditions precedent as set forth in the agreement. Zylox-Tonbridge is principally engaged in the research, development, manufacturing, and sales of neuro- and peripheral vascular interventional products. The seller, E-Med Solutions, is primarily engaged in the development, manufacturing, and distribution of medical technology products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL6YJcnY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","02190","BK1583","BK1100"],"gpt_icon":0},{"id":"2603811939","title":"Zylox-Tonbridge Medical Technology - Deal for EUR18.375 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2603811939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603811939?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:11","pubTimestamp":1768515113,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG1MD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02190","BK1100","BK1587","BK1574","BK1583"],"gpt_icon":0},{"id":"2603793986","title":"Zylox-Tonbridge Medical Technology Co Ltd - Acquisition of 49% Equity Interests Optimed Holding Gmbh","url":"https://stock-news.laohu8.com/highlight/detail?id=2603793986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603793986?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:11","pubTimestamp":1768515113,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG1MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1574","02190","BK1583","BK1100"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zyloxmedical.com","stockEarnings":[{"period":"1week","weight":-0.08},{"period":"1month","weight":-0.1367},{"period":"3month","weight":-0.1166},{"period":"6month","weight":-0.1945},{"period":"1year","weight":0.7006},{"period":"ytd","weight":-0.1143}],"compareEarnings":[{"period":"1week","weight":-0.0566},{"period":"1month","weight":-0.057},{"period":"3month","weight":-0.0265},{"period":"6month","weight":-0.0066},{"period":"1year","weight":0.1006},{"period":"ytd","weight":-0.0149}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Zylox-Tonbridge Medical Technology Co Ltd is a China-based company primarily engaged in the provision of solutions to patients and physicians with the product portfolio covering neurovascular interventional devices and peripheral vascular interventional devices. The neurovascular interventional devices primarily include SilverSnake Intracranial Support Catheter, Phoenix Neurovascular Embolization Coil, Tonbridge Kylin Flow Diverter, Thrombite Clot Retriever Device and Beidou SS Neurovascular Guidewire. The peripheral vascular interventional devices primarily include UltraFree Drug Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, ZYLOX Octoplus Retrievable Inferior Vena Cava Filter, Snare Retrieval Kit for Inferior Vena Cava Filter and ZYLOX Swan Endovenous Radiofrequency Ablation Catheter. The Company primarily operates its businesses in the domestic market and overseas markets, including Germany, France, Italy, and Turkiye.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.038267},{"month":2,"riseRate":0.4,"avgChangeRate":-0.097164},{"month":3,"riseRate":0.4,"avgChangeRate":-0.003993},{"month":4,"riseRate":0.75,"avgChangeRate":0.111063},{"month":5,"riseRate":0.5,"avgChangeRate":-0.029077},{"month":6,"riseRate":0.75,"avgChangeRate":0.088544},{"month":7,"riseRate":0.5,"avgChangeRate":-0.038763},{"month":8,"riseRate":0.4,"avgChangeRate":-0.049708},{"month":9,"riseRate":0.6,"avgChangeRate":0.019857},{"month":10,"riseRate":0.2,"avgChangeRate":-0.028854},{"month":11,"riseRate":0.6,"avgChangeRate":0.041084},{"month":12,"riseRate":0.6,"avgChangeRate":0.027438}],"exchange":"SEHK","name":"ZYLOXTB","nameEN":"ZYLOXTB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ZYLOXTB(02190),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ZYLOXTB(02190) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ZYLOXTB,02190,ZYLOXTB股票,ZYLOXTB股票老虎,ZYLOXTB股票老虎国际,ZYLOXTB行情,ZYLOXTB股票行情,ZYLOXTB股价,ZYLOXTB股市,ZYLOXTB股票价格,ZYLOXTB股票交易,ZYLOXTB股票购买,ZYLOXTB股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ZYLOXTB(02190),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ZYLOXTB(02190) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}